Results 51 to 60 of about 22,412 (196)
ABSTRACT Introduction D‐dimers are produced by lysis of cross‐linked fibrin. In children, D‐dimer testing is used to evaluate disseminated intravascular coagulation (DIC) and some inflammatory states, but its use is not validated for screening or ruling out suspected venous thromboembolic events (VTE).
Rabab Al Dawood +4 more
wiley +1 more source
Confusing combination of thrombocytopenia and thrombosis after heparin therapy in a patient with cardiac leiomyosarcoma; a nephrologist viewpoint [PDF]
We represent here a 30-year-old woman with cardiac leiomyosarcoma who developed thrombocytopenia and deep vein thrombosis a few days after the start of low molecular weight heparin.
Ardalan Mohammad-Reza
doaj
We report the case of a 35-year-old pregnant woman (gravida 3, para 1) with antithrombin deficiency who was successfully treated with apixaban. She had a history of heparin-induced thrombocytopenia and venous thromboembolic events.
Mayuko Komori +5 more
doaj +1 more source
Objective Diffuse alveolar hemorrhage (DAH) is a life‐threatening presentation of antineutrophil cytoplasmic antibody–associated vasculitis (AAV). Patients with AAV are at an increased risk of venous thromboembolic events (VTEs). These manifestations can co‐occur; however, the prognosis and management of these patients are poorly understood. Methods In
Elif D. Ediboglu +5 more
wiley +1 more source
Although both coronary artery dissection and heparin-induced thrombocytopenia may provoke myocardial infarction, it is extremely rare for both conditions to develop simultaneously in a single patient. We report a case of a 69-year-old woman who sustained
Michael G. Fradley, Douglas E. Drachman
doaj +1 more source
Anti‐platelet factor 4/heparin antibodies in patients with Hantaan virus infection
Background Hemorrhagic fever with renal syndrome (HFRS) induced by Hantaan virus infection and heparin‐induced thrombocytopenia (HIT) are associated with symptoms such as thrombocytopenia and thrombosis.
Meng Wang +10 more
doaj +1 more source
Cytokine‐engineered CAR‐T cells represent a promising immunotherapy against malignancies due to direct tumor killing and potent immunity response. However, significant toxicities, including CRS and ICANS, have restricted clinical applications. How to keep the risk‐benefit balance of the advanced therapy is of great importance for maximizing the benefit
Xinru Zhang +7 more
wiley +1 more source
HEPARIN-INDUCED THROMBOCYTOPENIA (REVIEW)
Heparin-induced thrombocytopenia (HIT) is a serious and potentially life-threatening side effect of heparinotherapy. It is an antibody-mediated process that causes platelet activation, increases the procoagulant characteristics of the blood and, as a ...
S. A. Vasiliev +6 more
doaj +1 more source
Heparin-induced thrombocytopenia occurring after surgical treatment of atrial myxoma: A case report [PDF]
Introduction Heparin-induced thrombocytopenia (HIT) is an acquired, prothrombotic disorder, caused by antibodies to a complex of heparin and platelet factor 4 (PF4) that activates platelets, resulting in the release of procoagulant microparticles ...
Đunić Irena +7 more
doaj +1 more source
Both Double‐Filtration Plasmapheresis (DFPP) and efgartigimod effectively treat acute exacerbations of generalized myasthenia gravis (gMG), with efficacy rising across successive sessions. In moderate‐to‐severe gMG, 3/5‐session DFPP outperformed 4‐infusion efgartigimod, while efficacy was comparable in mild cases.
Kan Wang +16 more
wiley +1 more source

